Peginterferon alfa-2b Injection

DRUG3 trials

Sponsors

Xiamen Amoytop Biotech Co., Ltd., Guangzhou 8th People's Hospital, Nanfang Hospital, Southern Medical University

Conditions

AIDSChronic Hepatitis BChronic Hepatitis B VirusHBVHepatitis B

Phase 3

A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B

CompletedNCT04846491

Xiamen Amoytop Biotech Co., Ltd.Chronic Hepatitis B

Start: 2019-12-04End: 2023-12-07Updated: 2024-03-05

Phase 4

Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B

Not yet recruitingNCT07231276

Nanfang Hospital, Southern Medical UniversityChronic Hepatitis B Virus, HBV

Start: 2026-01-01End: 2028-10-01Target: 113Updated: 2025-11-17

Unknown Phase

Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

RecruitingNCT05988879

Guangzhou 8th People's HospitalAIDS, Hepatitis B

Start: 2023-08-02End: 2028-08-02Target: 60Updated: 2023-08-14